Sign In
Buy CDNA
$28.50
-0.780 (-2.66%)
At Close: Jun 30, 2026
CareDx Announces Completion of Sale of Lab Products Business to Eurobio Scientific
04:05pm, Tuesday, 30'th Jun 2026
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clini
CareDx's CEO Sells 17K Shares
09:38pm, Sunday, 21'st Jun 2026
The CEO sold 17,683 shares for a transaction value of approximately ~$425,000 at a weighted average of around $24.03 per share on June 15. The transaction represented 2.7% of John Hanna's direct holdi
CareDx (CDNA) Moves 11.5% Higher: Will This Strength Last?
08:41am, Friday, 19'th Jun 2026
CareDx (CDNA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in t
CareDx Precision Medicine Diagnostics Showcased in Over 30 Abstracts and 9 Oral Presentations at the 2026 American Transplant Congress
07:05am, Thursday, 18'th Jun 2026
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clini
CareDx Inc (CDNA) Shares Fall 3.4% -- GF Value Says Still Overvalued
08:03pm, Tuesday, 16'th Jun 2026
On June 16, 2026, CareDx Inc (CDNA) shares fell by 3.4% to a current price of $23.22. The stock has experienced a 52-week range with a high of $24.85 and a low
CareDx Announces Second KOAR Analysis Published in the Journal of the American Society of Nephrology
04:05pm, Tuesday, 16'th Jun 2026
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clini
CareDx Sharpens Precision Diagnostics Push With Naveris Deal, AlloHeme Plans
08:04pm, Monday, 08'th Jun 2026
CareDx NASDAQ: CDNA executives outlined the company's strategy to focus on precision diagnostics, expand into minimal residual disease testing and improve profitability during a Goldman Sachs-hosted d
CareDx, Inc. (CDNA) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
04:38pm, Monday, 08'th Jun 2026
CareDx, Inc. (CDNA) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Baron Discovery Fund Q1 2026: Who Moved The Needle
01:35am, Monday, 08'th Jun 2026
In the first quarter of 2026, Baron Discovery Fund declined 10.65% (Institutional Shares), trailing the Russell 2000 Growth Index by 7.84% due to significant underperformance in the software sector. A
CareDx Highlights 39% Q1 Growth, Naveris Oncology Push at Jefferies
06:04am, Sunday, 07'th Jun 2026
CareDx NASDAQ: CDNA executives outlined the company's growth strategy, first-quarter performance and pipeline priorities during a presentation at the Jefferies Healthcare Conference, emphasizing trans
CareDx to Participate in Upcoming Investor Conferences
04:01pm, Wednesday, 20'th May 2026
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clini
CareDx Announces Dismissal of 2021 Qui Tam Suit
04:05pm, Monday, 11'th May 2026
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clini
CareDx, Inc. (CDNA) Q1 2026 Earnings Call Transcript
07:43am, Monday, 04'th May 2026
CareDx, Inc. (CDNA) Q1 2026 Earnings Call Transcript
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:01pm, Friday, 01'st May 2026
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA), — The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of c
CareDx (CDNA) Q1 Earnings and Revenues Top Estimates
06:48pm, Tuesday, 28'th Apr 2026
CareDx (CDNA) came out with quarterly earnings of $0.34 per share, beating the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.09 per share a year ago.
